Related Experiment Videos
Differential CD95 expression and function in T and B lineage acute lymphoblastic leukemia cells
L Karawajew1, C Wuchter, V Ruppert
1Department of Hematology, Oncology, and Tumor Immunology, Robert-Rössle Clinic, Humboldt University of Berlin, Germany.
Leukemia
|August 1, 1997
Summary
Most acute lymphoblastic leukemia (ALL) cells express CD95 (Fas/APO-1) but are resistant to its apoptosis-inducing function. Further research into signaling pathways is needed to understand this resistance in leukemia.
Area of Science:
- Immunology
- Molecular Biology
- Oncology
Background:
- CD95 (Fas/APO-1) is a cell surface receptor that can induce apoptosis.
- Acute lymphoblastic leukemia (ALL) is a cancer of the blood and bone marrow.
- Understanding apoptosis regulation in ALL is crucial for developing new therapies.
Purpose of the Study:
- To investigate the expression and function of CD95 in B-lineage and T-lineage ALL.
- To determine the correlation between CD95 expression levels and its apoptotic function in ALL cells.
- To explore the role of Bcl-2 in CD95-mediated apoptosis resistance in ALL.
Main Methods:
- Immunofluorescence staining to assess CD95 surface antigen expression.
- Apoptosis assays to evaluate CD95-induced cell death.
- Analysis of Bcl-2 expression in relation to apoptosis.
Main Results:
- CD95 was expressed on most ALL cells, with higher intensity in T-lineage ALL.
- The majority of ALL cells (75%) were resistant to CD95-triggered apoptosis.
- No significant correlation was found between CD95 expression levels and its apoptotic function, or between Bcl-2 expression and apoptosis in ALL cells.
- T-lineage ALL showed a higher sensitivity to CD95-induced apoptosis compared to B-lineage ALL.
Conclusions:
- ALL cells are predominantly resistant to CD95-mediated apoptosis despite CD95 expression.
- Mechanisms of intracellular apoptotic signaling, including Bcl-2 family interactions and ICE-like proteases, warrant further investigation for insights into ALL apoptosis resistance.